Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Camden Property Trust
CPT
$11B
| $13.1M | 0.01% |
97,477
-81,763
| -46% | -$12.1M |
|
902
CALL
Texas Instruments
TXN
$252B
| $13.1M | 0.01% |
+85,100
| New | +$14.3M |
|
903
Murphy USA
MUSA
$11.2B
| $13.1M | 0.01% |
56,054
+50,697
| +946% | +$12M |
|
904
Cytokinetics
CYTK
$10.5B
| $12.9M | 0.01% |
328,281
+247,104
| +304% | +$9.95M |
|
905
Lucid Motors
LCID
$2.88B
| $12.9M | 0.01% |
75,123
-4,251
| -5% | -$808K |
|
906
Masco
MAS
$14.1B
| $12.9M | 0.01% |
254,194
-85,919
| -25% | -$4.54M |
|
|
MGI
907
DELISTED
MoneyGram International, Inc. New
MGI
| $12.9M | 0.01% |
1,285,019
+982,205
| +324% | +$9.89M |
|
908
CarMax
KMX
$8.13B
| $12.8M | 0.01% |
141,954
-51,534
| -27% | -$4.85M |
|
909
Avantor
AVTR
$9.32B
| $12.8M | 0.01% |
412,842
+61,842
| +18% | +$1.93M |
|
910
CALL
Starbucks
SBUX
$120B
| $12.8M | 0.01% |
+168,000
| New | +$12.9M |
|
911
PUT
3M
MMM
$90.9B
| $12.8M | 0.01% |
+118,404
| New | +$14.3M |
|
|
COOL
912
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $12.8M | 0.01% |
1,297,755
+216,398
| +20% | +$2.13M |
|
|
IPG
913
DELISTED
Interpublic Group of Companies
IPG
| $12.8M | 0.01% |
464,329
-569,344
| -55% | -$18.1M |
|
914
SolarEdge
SEDG
$2.51B
| $12.7M | 0.01% |
46,488
-17,618
| -27% | -$4.82M |
|
915
Zebra Technologies
ZBRA
$14B
| $12.7M | 0.01% |
43,256
-17,438
| -29% | -$6.07M |
|
916
Snap-on
SNA
$21.2B
| $12.6M | 0.01% |
64,166
-14,224
| -18% | -$3.03M |
|
917
Magna International
MGA
$18.7B
| $12.6M | 0.01% |
229,747
+131,164
| +133% | +$7.99M |
|
918
J.M. Smucker
SJM
$12.7B
| $12.5M | 0.01% |
97,972
-158,345
| -62% | -$21.1M |
|
919
PUT
General Motors
GM
$80.4B
| $12.5M | 0.01% |
+394,600
| New | +$14.8M |
|
920
Altimmune
ALT
$552M
| $12.5M | 0.01% |
1,065,547
-89,734
| -8% | -$553K |
|
921
Globe Life
GL
$14.2B
| $12.4M | 0.01% |
126,940
-62,821
| -33% | -$6.16M |
|
922
Ball Corp
BALL
$17.3B
| $12.4M | 0.01% |
179,747
-200,408
| -53% | -$15.2M |
|
923
EPAM Systems
EPAM
$5.51B
| $12.4M | 0.01% |
41,905
-17,015
| -29% | -$5.2M |
|
924
Cheniere Energy
CQP
$31.9B
| $12.3M | 0.01% |
274,390
+143,833
| +110% | +$7.57M |
|
925
PUT
SoFi Technologies
SOFI
$21B
| $12.3M | 0.01% |
2,324,400
-244,800
| -10% | -$1.65M |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.